T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer

Clinical trial NCT03530696 · COMPLETED

Trial details

NCT number: NCT03530696
Sponsor: University of Arizona
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Breast Cancer Breast Cancer Stage Recurrent Breast Cancer Metastatic Breast Cancer HER2 Positive Breast Carcinoma

Start date: 2018-12-06
Primary completion: 2022-12-22
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.